Relebactam
Relebactam (MK-7655) is a novel β-lactamase inhibitor that inhibited both class A and C β-lactamases in vitro; effectively restored imipenem's activity against imipenem-resistant Pseudomonas and Klebsiella strains at clinically achievable concentrations; reduces imipenem MICs for Enterobacteriaceae with KPC carbapenemases from 16-64 mg/L to 0.12-1 mg/L at a concentration of 4 mg/L.Bacterial Infection Phase 3 Clinical (In Vitro) :Relebactam combine with Imipenem demonstrates activity against KPC-producing Enterobacteriaceae and multidrug-resistant P. aeruginosa.Relebactam shows limited inhibition of Class D-producing bacteria and has antipseudomonal activity.
Product Specifications
CAS Number
1174018-99-5
Product Name Alternative
MK-7655
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
O=S (O) (ON1[C@]2 ([H]) CC[C@@H] (C (NC3CCNCC3) =O) [N@@] (C2) C1=O) =O
Molecular Formula
C12H20N4O6S
Molecular Weight
348.3754
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Sulfuric acid, mono[ (1R,2S,5R) -7-oxo-2-[ (4-piperidinylamino) carbonyl]-1,6-diazabicyclo[3.2.1]oct-6-yl] ester
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Flt3, Cytoplasmic (Fms-like Tyrosine Kinase 3, CD135) (MaxLight 550) discontinued
